Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
2.110
+0.010 (0.48%)
Sep 18, 2024, 1:33 PM EDT - Market open

Caribou Biosciences Revenue

Caribou Biosciences had revenue of $3.46M in the quarter ending June 30, 2024, a decrease of -7.75%. This brings the company's revenue in the last twelve months to $33.11M, up 132.34% year-over-year. In the year 2023, Caribou Biosciences had annual revenue of $34.48M with 148.91% growth.

Revenue (ttm)
$33.11M
Revenue Growth
+132.34%
P/S Ratio
5.59
Revenue / Employee
$209,576
Employees
158
Market Cap
190.67M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202334.48M20.63M148.91%
Dec 31, 202213.85M4.25M44.31%
Dec 31, 20219.60M-2.76M-22.35%
Dec 31, 202012.36M6.57M113.56%
Dec 31, 20195.79M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ModivCare 2.77B
TruBridge 336.56M
Amylyx Pharmaceuticals 298.76M
biote 187.23M
Innate Pharma 36.20M
Stereotaxis 23.75M
Profound Medical 7.88M
Orchestra BioMed Holdings 2.08M
Revenue Rankings